Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Jacobi Pharma-Service GmbH Address & Contact
Website
Overview of Jacobi Pharma-Service GmbH
The Jacobi Pharma-Service GmbH based in Heppenheim, Hesse, has established itself as a reliable contract manufacturer and contract filler for liquids and creams. The specialization in contract manufacturing encompasses a wide range of pharmaceutical products as well as related products used in various application areas. From the initial concept through development to final filling, the company offers solutions for numerous industry-related challenges. Jacobi Pharma-Service GmbH operates both as a Contract Manufacturing Organization (CMO) and as a Contract Development and Manufacturing Organization (CDMO), enabling comprehensive support for clients throughout the entire product lifecycle.
GMP Standards and Approval
The GMP certification (Good Manufacturing Practice) is an indispensable requirement for contract manufacturers in Germany, and Jacobi Pharma-Service GmbH fully meets these high standards. The manufacturing license according to § 13 of the Medicines Act (AMG) certifies the company's qualification, while compliance with the EU-GMP guidelines involves regular controls and inspections by the responsible regional authority. The results of these inspections confirm the quality and safety of the products manufactured in a closely monitored environment. The company employs highly qualified personnel who are not only capable of validating complex manufacturing processes but also ensure that every batch is fully documented.
Pharmaceutical Manufacturing in Heppenheim
The location in Heppenheim, a city with significant industrial tradition, provides Jacobi Pharma-Service GmbH with not only excellent logistical connections but also access to a network of qualified professionals and other service providers. This strengthens competitiveness and enables a flexible response to market demands. Production takes place in modern, fully equipped facilities designed for the manufacturing of a variety of formulations, ranging from solutions and emulsions to creams and semi-solids. This benefits pharmaceutical companies and biotech firms that wish to develop specific product lines under a strict regulatory framework.
Product Areas and Regional Importance
Jacobi Pharma-Service GmbH produces a variety of products that are situated in the areas of pharmaceuticals, cosmetics, and healthcare. These include among others:
- Liquid medicines
- Creams and ointments
- Active Pharmaceutical Ingredients (API)
- Medical devices in liquid form
The regional importance of the company is also remarkable. Through close cooperation with local universities and research institutions, Jacobi Pharma-Service contributes to the training of the next generation of professionals in the pharmaceutical field. Additionally, the company is involved in the local economy and promotes the creation of jobs in the region. These partnerships have not only contributed to strengthening the industry but also to the innovative capacity in the region by developing new technologies and methods to improve production processes.
Special Features and Future Perspectives
A notable feature of Jacobi Pharma-Service is the flexibility in the production process, allowing for tailored solutions for different batch sizes - from small batches for clinical trials to large-scale productions for international distribution. The company places great importance on sustainability by integrating environmentally friendly manufacturing processes and recycling management. In the future, Jacobi Pharma-Service focuses on expanding its product portfolio, particularly in the area of biopharmaceutical products and innovative formulations, to continue responding to the changing demands of the market.
For more information about Jacobi Pharma-Service GmbH and their offerings, click here.
Frequently asked questions about Jacobi Pharma-Service GmbH
Was bietet Jacobi Pharma-Service GmbH als Lohnhersteller an?
Jacobi Pharma-Service GmbH bietet pharmazeutische Auftragsherstellung (CMO/CDMO) in Heppenheim, Hessen an – von der Entwicklung bis zur fertigen Charge nach GMP-Standard.
Welche Zulassungen hat Jacobi Pharma-Service GmbH?
Als Lohnhersteller verfügt Jacobi Pharma-Service GmbH über eine Herstellungserlaubnis nach § 13 AMG sowie GMP-Zertifizierung gemäß EU-Richtlinien.
Wie nehme ich Kontakt mit Jacobi Pharma-Service GmbH auf?
Adresse und Kontaktdaten von Jacobi Pharma-Service GmbH in Heppenheim, Hessen finden Sie auf dieser Sanoliste-Seite.
Contract Manufacturers in Germany
Related areas in healthcare
Contract Manufacturers by location
About Contract Manufacturers
A contract manufacturer, often referred to internationally as a Contract Manufacturing Organisation (CMO), produces medicines or medical products on behalf of another company (the marketing authorisation holder) without itself holding the marketing authorisation for the finished product. Contract manufacturing is a well-established and growing model in the pharmaceutical industry, allowing brand holders, biotech startups and generic companies to outsource manufacturing capacity while focusing on research, regulatory affairs and commercial activities. In Germany, operating as a pharmaceutical contract manufacturer requires a manufacturing authorisation (Herstellungserlaubnis) issued under Section 13 of the AMG (German Medicinal Products Act). Without this authorisation it is not permitted to manufacture, fill, package or release medicinal products for commercial use. Alongside the manufacturing authorisation, CMOs must produce in full compliance with Good Manufacturing Practice (GMP) standards, as defined in Annex I of Directive 2003/94/EC and the EU GMP Guidelines (EudraLex Volume 4). GMP compliance is verified through regular announced and unannounced inspections carried out by the competent pharmaceutical supervisory authority of the relevant German state (Landesbehörde). Services offered by German CMOs span the entire production chain: active pharmaceutical ingredient (API) synthesis, formulation development, solid dosage forms (tablets, capsules, granules), semi-solid and liquid forms, sterile manufacturing (injectables, infusions, eye drops), biological products, packaging (primary and secondary) and quality control and release testing. This directory lists all GMP-certified contract manufacturers in Germany with their manufacturing authorisation under Section 13 AMG and full contact details.
Contract Manufacturing in the German Pharmaceutical Industry
Contract pharmaceutical manufacturing in Germany has grown significantly over recent decades as global pharmaceutical companies seek to optimise their manufacturing footprints and reduce capital expenditure on production capacity. German CMOs benefit from the country's engineering expertise, well-trained workforce, strong regulatory standing and proximity to European clients. The German CMO market serves a diverse client base: established pharmaceutical companies outsourcing non-core production, generic manufacturers seeking additional capacity, biotech startups without their own manufacturing facilities, and international companies seeking a European manufacturing base with GMP certification recognised by the EMA and FDA. The services offered by German CMOs span the full development-to-commercial lifecycle, from formulation and process development in the lab through pilot-scale production and technology transfer to full commercial manufacturing and distribution. Germany's high GMP standards mean that products manufactured by German CMOs are accepted in regulatory submissions worldwide.
GMP Requirements and State Inspections for German CMOs
All pharmaceutical contract manufacturers in Germany must operate in compliance with EU GMP guidelines (EudraLex Volume 4) as a condition of holding a manufacturing authorisation under Section 13 of the AMG. GMP covers every aspect of pharmaceutical manufacturing: facility design and qualification, equipment qualification and calibration, cleaning validation, process validation, personnel training and hygiene, starting material and finished product testing, batch record documentation, stability studies, and management of deviations, out-of-specification results and change controls. GMP compliance is verified through inspections conducted by the pharmaceutical supervisory authority of the relevant German federal state (Landesbehörde). Inspections may be routine, announced or unannounced. Inspection findings are classified by severity (critical, major, minor) and manufacturers must respond with corrective and preventive action plans (CAPAs). GMP inspection results are entered into the EudraGMDP database. Foreign regulatory authorities such as the FDA, PMDA (Japan) and TGA (Australia) also conduct inspections of German CMOs that supply their markets.
Sterile Manufacturing and Specialised CMO Capabilities in Germany
Germany has a particularly strong track record in sterile pharmaceutical manufacturing, a technically demanding and heavily regulated segment of the CMO market. Sterile manufacturing encompasses injectable products (vials, ampoules, pre-filled syringes, cartridges), ophthalmic preparations (eye drops, eye ointments), inhalation solutions and infusion bags. These products must be manufactured in controlled cleanroom environments classified according to EU GMP Annex 1, which underwent a major revision in 2022 introducing the concept of contamination control strategy (CCS). Germany's engineering and cleanroom construction companies are world leaders in pharmaceutical facility design, making the country an attractive location for state-of-the-art sterile manufacturing investments. Beyond sterile manufacturing, German CMOs offer specialised capabilities in highly potent APIs (HPAPIs) and cytotoxic products requiring containment, modified-release oral dosage forms, transdermal drug delivery systems, biologics fill-and-finish, and clinical trial material manufacturing (CTMS).
Specialisations and the Growing Contract Manufacturing Market
The global market for pharmaceutical contract manufacturing is growing at approximately eight percent annually and is projected to exceed 300 billion US dollars by 2030. Growth drivers include the outsourcing strategy of large pharmaceutical companies, the growth of small biotech startups without their own production capacities and increasing demand for biologics and Advanced Therapy Medicinal Products (ATMPs). German contract manufacturers have established themselves in several niches: sterile manufacturing (injection solutions, lyophilisates) requires ultra-clean cleanrooms to ISO classifications; HPAPI containment (highly potent active pharmaceutical ingredients) requires specialist fume cupboards and personal protection measures; biologics CMOs require bioreactors and cell culture technology. CDMOs (Contract Development and Manufacturing Organizations) additionally offer formulation development and clinical trial materials. Important players in the German CMO market include Rentschler, Boehringer Ingelheim Biopharmaceuticals, Siegfried and Corden Pharma.
What is a pharmaceutical contract manufacturer?
A contract manufacturer (CMO) produces medicines or medical products on behalf of other companies. In Germany, CMOs require a manufacturing authorisation under Section 13 of the AMG (German Medicinal Products Act) and must comply with GMP (Good Manufacturing Practice) standards. They offer services across the entire production chain.
What requirements must contract manufacturers meet?
Contract manufacturers for medicines must hold a manufacturing authorisation under the AMG, produce in compliance with GMP standards and submit to regular inspections by the responsible state authorities. Qualification and validation of all manufacturing processes is mandatory.
How do I choose the right contract manufacturer?
When selecting a CMO, key criteria include GMP certification status, proven expertise in the desired dosage form (tablets, injectables, biologics, sterile products), production capacity, cleanroom classification, containment capabilities for HPAPIs and reference projects in the relevant product class. A structured supplier qualification process in line with GMP requirements is mandatory. All German CMOs with manufacturing authorisation under Section 13 AMG are listed on Sanoliste.
How many pharmaceutical contract manufacturers are there in Germany?
Germany is home to a significant number of GMP-certified contract manufacturers operating across a wide range of dosage forms and therapeutic areas. They range from large, multi-product contract manufacturing sites with hundreds of employees to smaller specialist CMOs focused on specific forms such as sterile injectables, biotechnology-derived products or controlled-release oral dosage forms. All those holding a manufacturing authorisation under Section 13 AMG are listed on Sanoliste.
What is the role of the Qualified Person (QP) at a German CMO?
The Qualified Person (Sachkundige Person, QP) is a legally required role under Section 14 of the AMG and EU Directive 2003/94/EC. The QP is personally responsible for certifying each batch of medicinal product before it is released onto the market, confirming that it has been manufactured and tested in accordance with GMP and the relevant marketing authorisation. Without a QP on site, a manufacturing authorisation under Section 13 AMG cannot be granted.
What types of dosage forms do German CMOs typically produce?
German CMOs cover a very broad range of dosage forms including conventional oral solid forms (tablets, capsules, granules, powders), liquid oral forms (solutions, suspensions, syrups), semi-solids (creams, ointments, gels), sterile injectables and infusions, eye drops, inhalation products, transdermal patches, biologics and biosimilars, APIs and active ingredient intermediates, and specialised forms such as modified-release or taste-masked products.
What is the difference between a CMO and a CDMO in Germany?
A CMO (Contract Manufacturing Organisation) focuses purely on manufacturing services. A CDMO (Contract Development and Manufacturing Organisation) additionally offers pharmaceutical development services such as formulation development, process development, analytical method development and scale-up support. Many German contract manufacturers have evolved into CDMOs, offering clients an integrated service from early development through to commercial manufacturing under one roof.